Literature DB >> 18769615

Interactions of natural health products with biomedical cancer treatments.

D Seely1, D Oneschuk.   

Abstract

The use of complementary and alternative medicine (CAM), including the ingestion of natural health products (NHPS), is common among cancer patients. Of concern to clinicians and patients alike is the possibility that cam, used concurrently with biomedical therapy, may interact poorly with that therapy, especially chemotherapy and radiotherapy. Proponents of NHPS argue that taking such products can help to reduce the side effects of conventional therapy and can provide an additional anticancer effect. However, opponents insist that the potential for harm is too great to warrant the risk of concurrent administration. There are promising examples of specific NHPS that may provide patient benefit even when given in close proximity both to chemotherapy and to radiotherapy, but unfortunately, in part because of a rather limited evidence base, caution is warranted when considering the issue of therapeutic interactions. Strategic application of NHPS before or after conventional therapy may be considered; however, concurrent application should be avoided as a general principle until further evidence is available regarding specific interactions.

Entities:  

Keywords:  Complementary medicine; antioxidants; cam; chemotherapy; drug–herb interactions; natural health products; nhps; pharmacology; radiotherapy

Year:  2008        PMID: 18769615      PMCID: PMC2528552     

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  9 in total

1.  Polysaccharide Peptide Extract From Coriolus versicolor Increased Tmax of Tamoxifen and Maintained Biochemical Serum Parameters, With No Change in the Metabolism of Tamoxifen in the Rat.

Authors:  Valentina Razmovski-Naumovski; Benjamin Kimble; Daunia Laurenti; Srinivas Nammi; Hisayoshi Norimoto; Kelvin Chan
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

2.  A multisite, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine.

Authors:  Patricia A Parker; Diana Urbauer; Michael J Fisch; Bryan Fellman; Holly Hough; Jessica Miller; Victor Lanzotti; Mindy Whisnant; Matthias Weiss; Lori Fellenz; Martin Bury; Patricia Kokx; Kathleen Finn; Maureen Daily; Lorenzo Cohen
Journal:  Cancer       Date:  2013-07-03       Impact factor: 6.860

3.  Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey.

Authors:  Buyadaa Oyunchimeg; Jung Hye Hwang; Mansoor Ahmed; Soojeung Choi; Dongwoon Han
Journal:  BMC Complement Altern Med       Date:  2017-01-19       Impact factor: 3.659

Review 4.  Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review.

Authors:  Monique Aucoin; Kieran Cooley; Christopher Knee; Heidi Fritz; Lynda G Balneaves; Rodney Breau; Dean Fergusson; Becky Skidmore; Raimond Wong; Dugald Seely
Journal:  Integr Cancer Ther       Date:  2016-06-29       Impact factor: 3.279

5.  Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.

Authors:  Guo-Shiou Liao; Maria Karmella Apaya; Lie-Fen Shyur
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-12       Impact factor: 2.629

Review 6.  Decision-making about complementary and alternative medicine by cancer patients: integrative literature review.

Authors:  Laura Weeks; Lynda G Balneaves; Charlotte Paterson; Marja Verhoef
Journal:  Open Med       Date:  2014-04-15

Review 7.  Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies.

Authors:  Gabriel Gazzé
Journal:  Melanoma Manag       Date:  2018-06-19

8.  Attitudes Underlying Reliance on Complementary and Alternative Medicine.

Authors:  Szilvia Zörgő; Gjalt-Jorn Ygram Peters; Samvel Mkhitaryan
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

Review 9.  Hidden in Plants-A Review of the Anticancer Potential of the Solanaceae Family in In Vitro and In Vivo Studies.

Authors:  Tomasz Kowalczyk; Anna Merecz-Sadowska; Patricia Rijo; Mattia Mori; Sophia Hatziantoniou; Karol Górski; Janusz Szemraj; Janusz Piekarski; Tomasz Śliwiński; Michał Bijak; Przemysław Sitarek
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.